234 related articles for article (PubMed ID: 24780467)
1. Protein-bound molecules: a large family with a bad character.
Sirich TL; Meyer TW; Gondouin B; Brunet P; Niwa T
Semin Nephrol; 2014 Mar; 34(2):106-17. PubMed ID: 24780467
[TBL] [Abstract][Full Text] [Related]
2. Albumin is the main plasma binding protein for indoxyl sulfate and p-cresyl sulfate.
Viaene L; Annaert P; de Loor H; Poesen R; Evenepoel P; Meijers B
Biopharm Drug Dispos; 2013 Apr; 34(3):165-75. PubMed ID: 23300093
[TBL] [Abstract][Full Text] [Related]
3. Removal of protein-bound, hydrophobic uremic toxins by a combined fractionated plasma separation and adsorption technique.
Brettschneider F; Tölle M; von der Giet M; Passlick-Deetjen J; Steppan S; Peter M; Jankowski V; Krause A; Kühne S; Zidek W; Jankowski J
Artif Organs; 2013 Apr; 37(4):409-16. PubMed ID: 23330821
[TBL] [Abstract][Full Text] [Related]
4. Numerous protein-bound solutes are cleared by the kidney with high efficiency.
Sirich TL; Aronov PA; Plummer NS; Hostetter TH; Meyer TW
Kidney Int; 2013 Sep; 84(3):585-90. PubMed ID: 23636170
[TBL] [Abstract][Full Text] [Related]
5. Protein-bound uremic toxins: new culprits of cardiovascular events in chronic kidney disease patients.
Ito S; Yoshida M
Toxins (Basel); 2014 Feb; 6(2):665-78. PubMed ID: 24561478
[TBL] [Abstract][Full Text] [Related]
6. Reduction in protein-bound solutes unacceptable as marker of dialysis efficacy during alternate-night nocturnal hemodialysis.
Meijers B; Toussaint ND; Meyer T; Bammens B; Verbeke K; Vanrenterghem Y; Kerr PG; Evenepoel P
Am J Nephrol; 2011; 34(3):226-32. PubMed ID: 21791919
[TBL] [Abstract][Full Text] [Related]
7. Release of uremic retention solutes from protein binding by hypertonic predilution hemodiafiltration.
Böhringer F; Jankowski V; Gajjala PR; Zidek W; Jankowski J
ASAIO J; 2015; 61(1):55-60. PubMed ID: 25419832
[TBL] [Abstract][Full Text] [Related]
8. Phenyl sulfate, indoxyl sulfate and p-cresyl sulfate decrease glutathione level to render cells vulnerable to oxidative stress in renal tubular cells.
Edamatsu T; Fujieda A; Itoh Y
PLoS One; 2018; 13(2):e0193342. PubMed ID: 29474405
[TBL] [Abstract][Full Text] [Related]
9. Exploring binding characteristics and the related competition of different protein-bound uremic toxins.
Deltombe O; de Loor H; Glorieux G; Dhondt A; Van Biesen W; Meijers B; Eloot S
Biochimie; 2017 Aug; 139():20-26. PubMed ID: 28528271
[TBL] [Abstract][Full Text] [Related]
10. Uremic solutes from colon microbes.
Meyer TW; Hostetter TH
Kidney Int; 2012 May; 81(10):949-954. PubMed ID: 22318422
[TBL] [Abstract][Full Text] [Related]
11. Improved dialysis removal of protein-bound uremic toxins by salvianolic acids.
Li J; Wang Y; Xu X; Cao W; Shen Z; Wang N; Leng J; Zou N; Shang E; Zhu Z; Guo J; Duan J
Phytomedicine; 2019 Apr; 57():166-173. PubMed ID: 30772752
[TBL] [Abstract][Full Text] [Related]
12. The gut-kidney axis: indoxyl sulfate, p-cresyl sulfate and CKD progression.
Meijers BK; Evenepoel P
Nephrol Dial Transplant; 2011 Mar; 26(3):759-61. PubMed ID: 21343587
[No Abstract] [Full Text] [Related]
13. Protein-bound uremic toxins - biological effects and impact on morbidity in patients with chronic kidney disease.
Gomółka M; Niemczyk S
Przegl Lek; 2017; 74(3):110-4. PubMed ID: 29694770
[TBL] [Abstract][Full Text] [Related]
14. Protein-bound uremic toxins: new insight from clinical studies.
Liabeuf S; Drüeke TB; Massy ZA
Toxins (Basel); 2011 Jul; 3(7):911-9. PubMed ID: 22069747
[TBL] [Abstract][Full Text] [Related]
15. Renal clearance and intestinal generation of p-cresyl sulfate and indoxyl sulfate in CKD.
Poesen R; Viaene L; Verbeke K; Claes K; Bammens B; Sprangers B; Naesens M; Vanrenterghem Y; Kuypers D; Evenepoel P; Meijers B
Clin J Am Soc Nephrol; 2013 Sep; 8(9):1508-14. PubMed ID: 23813557
[TBL] [Abstract][Full Text] [Related]
16. New insights into uremic toxicity.
Raff AC; Meyer TW; Hostetter TH
Curr Opin Nephrol Hypertens; 2008 Nov; 17(6):560-5. PubMed ID: 18941347
[TBL] [Abstract][Full Text] [Related]
17. Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration.
Krieter DH; Hackl A; Rodriguez A; Chenine L; Moragues HL; Lemke HD; Wanner C; Canaud B
Nephrol Dial Transplant; 2010 Jan; 25(1):212-8. PubMed ID: 19755476
[TBL] [Abstract][Full Text] [Related]
18. Association Between Kidney Clearance of Secretory Solutes and Cardiovascular Events: The Chronic Renal Insufficiency Cohort (CRIC) Study.
Chen Y; Zelnick LR; Huber MP; Wang K; Bansal N; Hoofnagle AN; Paranji RK; Heckbert SR; Weiss NS; Go AS; Hsu CY; Feldman HI; Waikar SS; Mehta RC; Srivastava A; Seliger SL; Lash JP; Porter AC; Raj DS; Kestenbaum BR;
Am J Kidney Dis; 2021 Aug; 78(2):226-235.e1. PubMed ID: 33421453
[TBL] [Abstract][Full Text] [Related]
19. Effects of AST-120 on blood concentrations of protein-bound uremic toxins and biomarkers of cardiovascular risk in chronic dialysis patients.
Lee CT; Hsu CY; Tain YL; Ng HY; Cheng BC; Yang CC; Wu CH; Chiou TT; Lee YT; Liao SC
Blood Purif; 2014; 37(1):76-83. PubMed ID: 24576840
[TBL] [Abstract][Full Text] [Related]
20. Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120.
Liu WC; Tomino Y; Lu KC
Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30208594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
